-
YM 58483 (BTP2) SOCE Blocker Guide
2026-09-10
This scenario-based guide explains how YM 58483 (BTP2), a store-operated Ca2+ entry (SOCE) blocker, can clarify calcium-dependent effects in viability, proliferation, cytotoxicity, T-cell, and fibrosis experiments. It provides practical handling guidance for SKU B7542, including solvent controls, concentration planning, interpretation, and vendor selection.
-
Paroxetine Mesylate: An Assay-First Guide
2026-09-10
Paroxetine Mesylate is more than a selective serotonin reuptake inhibitor: it is a useful model for connecting transporter pharmacology with kinase-centered cancer assays. This guide translates the MET/ERBB3 colorectal cancer evidence into practical, decision-oriented research workflows while defining its translational limits.
-
AP20187: A Precision Control Layer for Translation
2026-09-09
AP20187 is more than a chemical inducer of dimerization: it is a controllable experimental layer for testing how engineered protein interactions translate into cellular, metabolic, and cell-therapy outcomes. This thought-leadership analysis connects AP20187 mechanism with 14-3-3 signaling research while defining practical boundaries for translational development.
-
Pollen Spectral Interference in Bioaerosol Classification
2026-09-09
Zhang and colleagues developed a fluorescence-spectrum processing and random-forest workflow to reduce pollen interference during hazardous bioaerosol classification. Fast Fourier transform processing improved reported classification performance to 89.24%, while enabling clearer discrimination of bacterial and toxin-related samples.
-
Reversine and Phenotypic Assay Design
2026-09-08
Reversine is an Aurora kinase inhibitor that links mitotic perturbation to measurable cell-state phenotypes. This article shows how its multi-kinase profile can be evaluated alongside indexed, single-structure assays for sharper cancer and developmental research decisions.
-
Iptacopan (LNP023) Workflows for Complement Research
2026-09-08
Iptacopan (LNP023) enables selective alternative-pathway inhibition across serum, red-cell, and disease-model workflows. This guide translates its factor B mechanism and PNH evidence into practical assay design, controls, troubleshooting, and translational decisions.
-
Pentoxifylline: cAMP as a Translational Lever
2026-09-07
Pentoxifylline is more than a legacy circulation-support compound: its phosphodiesterase inhibition creates a testable link between cAMP elevation, macrophage reprogramming, nitric oxide control, and cytokine restraint. This thought-leadership guide connects the mechanism to experimental design, model selection, and translational decision-making.
-
L-Alanyl-L-Glutamine for Barrier Assays
2026-09-05
L-Alanyl-L-glutamine provides a water-based, solvent-free option for intestinal barrier workflows when free glutamine handling limits reproducibility. This guide combines practical dipeptide assay design with screening lessons from MERS-CoV research, while clearly separating validated evidence from proposed optimization steps.
-
Ferrostatin-1 in Phototherapy Ferroptosis Assays
2026-09-05
Ferrostatin-1 (Fer-1) can function as a causal control for distinguishing ferroptotic lipid damage from other ROS-driven effects in multimodal phototherapy. This article translates recent Co-SAE/HNCS findings into a practical assay strategy for cancer biology research and related disease models.
-
PPM-18: Translating NF-κB–iNOS Biology into Strategy
2026-09-04
PPM-18 provides a mechanistically defined way to study inducible nitric oxide synthase expression downstream of NF-κB activation. This thought-leadership perspective shows how translational researchers can connect promoter-level regulation, inflammatory biomarkers, redox biology, and sepsis-model endpoints without overstating preclinical evidence.
-
Tunicamycin as an ER Stress–Autophagy Probe
2026-09-04
Tunicamycin is a powerful N-glycosylation inhibitor for separating ER stress, inflammatory signaling, and autophagic flux. This article uses a recent Arabidopsis VPS41 study to show how compartment-specific readouts can make Tunicamycin experiments more mechanistically informative.
-
GI 254023X: Practical ADAM10 Assay Guide
2026-09-03
This scenario-based guide explains how GI 254023X (SKU A4436) can help researchers design more interpretable ADAM10 inhibition, viability, proliferation, and cytotoxicity experiments. It covers solvent handling, dose selection, endothelial and Jurkat models, data interpretation, and practical supplier-selection criteria.
-
Telmisartan in Cardiac Hypertrophy Research
2026-09-03
Use Telmisartan as a defined AT1-receptor perturbation tool in angiotensin II-driven cardiac hypertrophy models. Its receptor-proximal action complements emerging RIP3/CaMKII studies, helping researchers distinguish upstream renin–angiotensin signaling from downstream remodeling mechanisms.
-
Phenacetin in Human Intestinal Organoid Research
2026-09-02
Phenacetin offers a chemically defined probe for studying intestinal absorption and metabolism in human organoid systems. This article connects its physicochemical constraints with assay architecture, data interpretation, and the latest hiPSC-derived intestinal models.
-
EGCG Nanoparticles Strengthen FLASH Radiotherapy
2026-09-02
The reference study reports that functionalized, self-assembled epigallocatechin gallate nanoparticles, termed BENPs, intensify FLASH-RT-associated reactive oxygen species production, DNA damage, tumor-cell death, and antitumor immune activation in a preclinical breast cancer model. Its main practical contribution is a combined radiosensitization and immunomodulation strategy, although the findings remain preclinical and require validation across models, dose regimens, and clinically relevant treatment systems.